Longreads

The inside story of Ranbaxy, a generic drug maker that committed criminal fraud by fabricating data to win FDA approvals:

"Thakur knew the drugs weren't good. They had high impurities, degraded easily, and would be useless at best in hot, humid conditions. They would be taken by the world's poorest patients in sub-Saharan Africa, who had almost no medical infrastructure and no recourse for complaints. The injustice made him livid.

"Ranbaxy executives didn't care, says Kathy Spreen, and made little effort to conceal it. In a conference call with a dozen company executives, one brushed aside her fears about the quality of the AIDS medicine Ranbaxy was supplying for Africa. 'Who cares?' he said, according to Spreen. 'It's just blacks dying.'"

Photograph by Cody Picken

Carlos Gutierrez knows what it’s like to be terrified that the universe could suddenly turn against you. He felt it at age 6, when the Castro regime imprisoned his father. (Matt McClain / The…

The financial crisis had many causes—too much borrowing, foolish investments, misguided regulation—but at its core, the panic resulted from a lack of transparency. The reason no one…

For much of the past decade, General Electric’s storied Appliance Park, in Louisville, Kentucky, appeared less like a monument to American manufacturing prowess than a memorial to it. The very…

1. Wasserman The Amazon Effect Amazon got big fast, hastening the arrival of digital publishing. But how big is too big? Steve Wasserman, former editor of the Los Angeles Times Book Review, served as…